Back to today’s briefing

Story perspectives

GE HealthCare Stock at 52-Week Lows Amid Analyst Divisions

3/24/2026

49 11 Full Breakdown

Summary

Story summary

GE HealthCare Technologies trades near 52-week lows at about $69–$70 on Nasdaq.
Northside Capital increased its stake recently.
GMO Implementation Fund reduced its holdings recently.
Analysts are divided on the stock, with Jefferies and Evercore ISI raising targets to $105 and $98, and UBS issuing a sell rating with a $77 target.

1 of 1

Story summary

GE HealthCare Technologies trades near 52-week lows at about $69–$70 on Nasdaq.
Northside Capital increased its stake recently.
GMO Implementation Fund reduced its holdings recently.
Analysts are divided on the stock, with Jefferies and Evercore ISI raising targets to $105 and $98, and UBS issuing a sell rating with a $77 target.